Patents by Inventor Emmanuelle MEUILLET

Emmanuelle MEUILLET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and/or prevention of bone metastasis
    Patent number: 10179142
    Abstract: T-lymphocyte invasion and metastases (Tiam-1) has been identified as a marker and anti-cancer drug target for therapy of metastatic bone cancer in individuals afflicted with prostate cancer. The present disclosure provides methods and compounds for inhibiting metastases by disrupting Tiam-1 expression and activity. One particularly preferred compound comprises a disulfomanide of the formula.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: January 15, 2019
    Assignee: THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Emmanuelle Meuillet, Sylvestor Moses, Shuxing Zhang
  • TREATMENT AND/OR PREVENTION OF BONE METASTASIS
    Publication number: 20160213693
    Abstract: T-lymphocyte invasion and metastases (Tiam-1) has been identified as a marker and anti-cancer drug target for therapy of metastatic bone cancer in individuals afflicted with prostate cancer. The present disclosure provides methods and compounds for inhibiting metastases by disrupting Tiam-1 expression and activity. One particularly preferred compound comprises a disulfomanide of the formula.
    Type: Application
    Filed: September 4, 2014
    Publication date: July 28, 2016
    Inventors: Emmanuelle MEUILLET, Sylvestor MOSES, Shuxing ZHANG